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Abstract 
Ventilatory treatment of neonatal respiratory distress often results in bronchopulmonary dysplasia 
from congenital surfactant deficiency due to mutants of transporter protein ABCA3. Association 
of this condition with other severe disorders in premature newborns has not heretofore been 
reported. A neonatal autopsy included an in vivo whole blood sample for genetic tcsting. 
Autopsy revealed severe interstitial pulmonary fibrosis at age 8 days with heterozygotic mutation 
p.E292V of ABCA3 and severe dystrophic retardation of cerebral cortcx and cerebellum. 
Subsequently, 1300 archival neonatal autopsies, 1983-2006, were reviewed for comparable 
concurrent findings and bronchopulmonary dysplasia or retarded cerebral dystrophy lacking the 
other principal feature of this syndrome. Archival review revealed four similar cases and eight 
less so, without gene analysis. Further review for bronchopulmonary dysplasia revealed 59 cases, 
1983-2006. Several other examples of similar retarded migration of germinal matrix and 
underdevelopment of cortical mantle, without pulmonary lesions of this type, were identified. The 
determination of an ABCA3 mutation in one case of severe pulmonary fibrosis with significant 
dystrophy of the brain and the identification of four highly similar archival cases and eight others 
with partial pathological findings supports the designation of an independent disorder, here 
referred to as the cerebroprrlmonary dysgenetic syndrome. 
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The first description and pathogenetic study of bronchopulmonary dysplasia, a complication of the 
evolving treatment of neonatal respiratory distress of the day, was forty years ago by Northway, 
Rosan, and Porter (1 967). Interstitial pulmonary hypercel lularity and progressive fibrosis were the 
principal features of the lung lesion when first described by thcm whcrcas othcrs, such as 
Robertson (1963, 1964) and Barter, et al. (1 966) emphasized the findings in the ternlinal airspaces. 
Indeed, Barter, et a1.(1966) noted hyaline membrane formation was rarely seen in infants only four 
days old, describing their observations as late results. 
By contrast, Northway and associatcs continued after 1967 to call attention to and to make fbrther 
observations on the interstitial component of longer term sequelae of pressure based ventilatory 
support and oxygen enrichment (Northway and Rosan, 1968; Northway and Rosan, 1969; Bonikos 
et al., 1976; Edwards et al., 1977; Northway, 1979; Northway, 1990; Northway et al., 1990; 
Northway, 1992; Howling et al., 2000). An early study of thc long tcrm radiographic findings dates 
from 1968. (Shepard et al., 1968). Improvements in neonatal treatment since then have engendered 
rnore detailed studies of the progressive lung lesions identified in infants four to ten months old 
(Erickson et al., 1987) and young adult survivors (Howling et al., 2000). 
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This more recent emphasis has overshadowed early work on the first phase of the lesion complex 
of hyaline membrane disease, including associated interstitial and air space hemorrhage, (Shanklin 
and Wolfson, 1967), and focal necrosis of terminal bronchiolar epithelium (Barter et al., 1966; 
Shanklin, 1971; de la Monte et al., 1986). 
Evidence is now accumulating for a genetic factor in the ability of the pulmonary interstitium to 
respond to either the primary pathogenesis or as an adverse factor in lung healing over time, or 
both, specifically mutations of the gene for ATP-binding cassette transporter protein, ABCA3 
(Matsumura et al., 2006; Somaschini et al., 2007; Guala et al., 2007). 
This development offers an explanation for early severe onset of pulmonary fibrosis with a high 
failure rate in hyaline membrane disease and led, in the index case, to the discovery of another 
serious developn~ental defect, in the brain. This combination of lesions, perhaps with other 
associated findings, has implications challenging for diagnosis, both clinical and pathological, and 
neonatal intensive care, and for further research at molecular, cellular, and genetic levels. 
Clinical history. 
Prenatal course was normal for a 30 year old primigravida until the 34th week when labor began by 
premature rupture of membranes. Betamethasone and penicillin G were given before the spontaneous 
vaginal delivery, after a total labor of 18 hours. The neonatal Apgar scores were 8 at 1 minute, 9 at 
5 minutes. A female infant weighed 1770 grams. Curosurf (1 dose) and face oxygen were provided. 
There was deterioration of cardioventilatory activity and she was placed on nasal CPAP, thence 
mechanical ventilation at 17.5 hours of life. Chest films showed hazy granular lungs with air 
bronchograms. Blood cultures were negative. The infant remained refractory and was transferred to 
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our NICU on the 4Ih day and placed on the oscillator. The ductus was patent with bidirectional flow 
by echocardiogram; there was a dilated left atrium and cardiomegaly. 
Pressor support was by dopamine and dobutamine and Indocin to close the ductus (3 doses). 
Antibiotics were continued. The next four days were complicated by refractory respiratory failure, 
persistent hyaline membrane disease, marked hypercarbia, severe acidosis, hypotension, and 
secondary cardiac failurc. The CRP rose >5.0 mg/dl; on the 7th day the final WBC was 6,000mm3. 
On the 8th day, tension pneumothorax occurred which was treated by drainage tube. A patient 
management conference with family discussed the poor prognosis: the decision was made to 
withdraw active support, replaced by comfort care. 
Placental and autopsyjindings. 
The placenta1:fetal weight ratio was 0.197, a median value for 34 weeks. There was generally 
normal developnlent and maturation of the villi, dilation and hypertrophy of deeper vascular 
networks, and marginal trophoblastic hyperplasia and dccidual rcdundancy consistent with 
zonal placenta extrachorialis. The autopsy proper revealed: (1) unresolved somatic prematurity, 
(2) far advanccd active progressive pulmonary fibrosis with focal remnants of hyaline membrane 
formation, (3) superimposed acute bronchiolitis and pneumonia, (4) myeloid hyperplasia, marrow 
and myeloid metaplasia, hepatic portal triads, (5) terminal systemic leukemoid reaction, 
(6) advanced cortical depletion of thymus, (7) cerebrocerebellar dystrophy consisting of general 
retardation of cerebral glioneuroblast migration, retention of much of the paraventricular germinal 
matrix (with in situ maturation), stasis of proxinlal migratory germinal matrix, absence of 
protopyramidal neuronal differentiation in layer 5 of parietal (motor) cortex, neuronal 
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underpopulation and immaturity of cortical mantle; dyssynchrony of purkinje cell maturation, 
cerebellum, with rctardcd dcvclopment and maturation of the outer folia, and focal arteriovenous 
malformations in the occipital cortical and cerebellar meninges, mesencephalon, and pons, (8) 
biventricular myocardial hypertrophy (35% above median value for body mass), (9) an 
endocrinopathy of uncertain type: retarded follicle formation, thyroid, with markedly enhanced 
trabecular fibrosis; eosinophile dominance, anterior pituitary; adrenal hypoplasia (combined 
weight, 2.8 g, median for birth weight, 4.8 i 0.3 g); hypoplasia of provisional adrenal cortcx; 
hyperplasia and early maturation, adrenal medulla, and one adrenal cortical nodule. Accessory 
findings included patent ductus arteriosus, small focal intrafolial cerebellar hemorrhages, minimal 
neuronal injury, extraniedullary erythropoiesis of liver and spleen, focal niyelopoiesis of central 
axial lymph nodes, isolated thrombosis of a renal arcuate artery, thrdnibosis/embolus in a marrow 
nutrient artery, status left post pneuniothorax, and status intravascular line placements. 
Specifically illustrated are the intense lung fibrosis (Figure l), the remnants of germinal matrix 
and in situ maturation (Figure 2), the immature parietal cortex lacking pyramidal cells in layer 
5 (Figure 3), and trabecular fibrosis of an immature, likely hypofunctional thyroid (Figure 4). 
Genetic report. 
From Ambry Genetics (Aliso Viejo, CA): heterozygotic mutation of ABCA3 full gene, known 
mutation p.E292V, the same mutation found in case #8 of Somaschini, et al. (2007), in 10 of 11 
patients reported by Bullard, et al. (2005) but not by Matsumura, et a1.(2006) or Shulenin, et 
a1.(2004). 
No novel or other reported variants were identified. 
Archival investigation. 
Twelve cases with lung and brain findings similar to those of the index case were identified over 
the interval 1991-2006; four of these had many aspects in common (Table 1). A fifth archival case 
with birth weight of 3368 g at 41 weeks survived 2 1 days. Thc lung showed massive superimposed 
lobular pneumonia and hemorrhage on 1 + bronchopulmonary dysplasia. There was gyromantle 
dysplasia with indistinct cortical layers, macrogyria, gliofibrillary meningcal nodules, bilateral 
narrow lateral dimension of basal ganglia, and far advanced fibrous septation of the thyroid with 
mixed collections of follicles typical of colloid goiter and others tightly compressed by the fibrosis. 
This case showed no remnant germinal matrix and was at term, suggestive of a major disturbance 
later in the migratory process. The greater niaturity and prolonged survival prompted our 
determination not to include it in the table of principal cases. 
In addition, a survey from the archives for 1983-2006 located 59 additional cases of 
bronchopulmonary dysplasia in 660 neonatal and infant autopsies (total database including 
stillborns, 1983-2006, 1280 autopsies with con~plete xamination of the central nervous system), 
for a total of 71 (10.76 per cent). The proportion of cases of pulmonary fibrosis putatively 
affected by ABCA3 mutations, from this perspective, is a remarkable 16.9 per cent, not a trivial 
subset of infants. Eight additional cases of comparable cerebrocerebellar dystrophy, without lung 
fibrosis, were found in this survey. While a small number, it is sufficient to suggest the possibility 
of multigenic effects interrelating these lesions and susceptibilities. 
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DISCUSSION 
This is a seeming case of first impression. The many conlplexities can be brought together as 
a condition here designated as the cerebropulmonary dysgenetic syndrome, on a provisional basis. 
Information now available in the medical and genetical literature makes it possible to establish 
a connection between two severe pathological disorders in premature newborns: 
1. Advanced and progressive pulmonary fibrosis, the late stage of hyaline membrane 
disease, well described as bronchopzrlrnonary &splasia. 
2. Maturational discordance in the central nervous system, more especially migrational delay 
from the gemlinal matrix with neuronal underpopulation of the cortical mantle as a 
principal result. Associated is persistcnt paravcntricular gcrnlinal matrix per se, with 
variable amounts of bulk migratory cells not far from their origin in the matrix, and, most 
remarkable, maturation of matrix in situ. 
The link between these seemingly disparate devastations of key tissues in the newborn infant 
lies with the demonstration of a ABCA3 heterozygotic mutant status in this case. ABCA3 is 
one mcmber of the ATP-binding casette transporter family A3, an important group of substance 
transport nlolecules (Dean et al., 2001). Mutations in the ABCA3 gene have been identified as a 
principal factor in fatal neonatal surfactant dcficicncy (Shulcnin et al., 2004; Bullard et al., 2005). 
Moreover, the ABCA3 mutants have been well characterized, classified, and localized in type 2 
pneumocytes which produce surfactant, (Matsumura et al., 2006), thus setting the cellular stage for 
the depletion of stored surfactant following the challenge of initial lung expansion (Bolande and 
Klaus, 1964), with an inability to replenish the surfactant. In addition, LBM180, a lamellar body 
limiting membrane protein of type 2 pneumocytes, has been identified as ABCA3 trailsporterprotein 
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(Mulugcta et a]., 2002). This finding solidifies the relationship of the protein to lung disorders 
common to premature newborns. 
The link between the pulmonary disorder and the abnormal brain lies in some exacting work on 
the brain of the developing mouse which establishes an abundance of the ABCA3 protein in 
cortical mantle(Tachikawa et al., 2005), sometimes referred to in the fetal mouse as the 
differentiating zone. ABCA3 is also found throughout the early brain, but is not upregulated 
post natally in the white matter after the migration is completed (Tachikawa et al., 2005). 
The superfanlily of human ABC genes is complex with expression ofABCA3 in lung and that of 
ABCA2 in brain (Dean et al., 2001). ABCA2 and ABCA3 are closely related in subgroup ABCA-I 
(Dean et al., 2001). The ABCA3 sequence is highly conserved in humans, rats, and mice in the 
region of the E292V mutation (Bullard et al., 2005), enhancing the validity of applying the results 
ofTachikawa, et a1 (2005) in mice to the scope of disorders here described as the cerebropulmonary 
dysgenetic syndrome. 
We have observed the unusual fibrous trabeculation of the thyroid occasionally but not 
systematically. Abnormal thyroid developn~ent and poor function were described in instances 
of global cerebral malformation by Shanklin (1991), offering the possibility of more than one 
factor at work in the endocrinopathy seen in our index case and in several from archival review. 
The genetic mutation behind this pathogenesis has been attributed to an autosoma1 recessive 
state in a study on 12 newborns (Guala, et al., 2007). By contrast, another report of similar size 
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(Somaschini, et al., 2007), identified three of 14 as heterozygotic mutants [their patients 7, 8, and 
131. Bullard, et al. (2005), described three older individuals (ages 11, 16, and 23 years) with the 
same missence mutation, E292V, found in our index patient, with a second mutation. These three 
patients has interstitial lung disease at their much later stage of life (Bullard, et al., 2005). These 
seeming discrepancies are evidence for compounded or multifactorial pathogenesis which may 
include such counterintuitive results as an autosoma1 dominant variant of the Wiskott-Aldrich 
syndrome, classically understood to be an X-linked recessive disease (Rocca, et al., 1996). It may 
be that certain regulatory proteins have to present in both parental genomes for proper function in 
the offspring. A variant allele through mutation can be sufficient to create an abnormal phenotype 
in that the haploid state of the wild type allele is inadequate for normal function. This is the case for 
a number of disorders. Women with heterozygous a-galactosidase mutations (Fabry disease) suffer 
from significant multisystemic disease, resulting in a reduced quality of life (Wang, et a]., 2007). 
Wang and associates studied 44 heterozygous women, a majority referred due to an affected male 
relative, of whom about 75% reported acroparesthesias as their first symptom (Wang, et al., 2007). 
Other symptoms were prominent such as fatigue with reduced oxygen consumption, exercise 
intolerance with low heart rate during exercise testing, and angina, symptoms charactcristic of thc 
homozygous state (Wang, et al., 2007). Comparable confounding heterozygotic abnormalities have 
been described for familial hypobetalipoproteinemia (Alapont Puchalt, et al., 2004). Perhaps the 
best example of enhanced risk for disease manifestations from the heterozygous mutant state is 
factor V Lcidcn (Glucck, et al., 2007; Herman, et al., 2006; In~perialc, ct al., 2007;Kalajian, et al., 
2007; Marchiori, et al., 2007; Verdu, et al., 2005). Marchiori, et al. (2007) estimated risk ratios 
on the order of 1.39 to 1.45, which, considcring the tendency for this trait to bccomc manifcst in 
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pregnancy, is an important health problem. At a fundamental cellular lcvcl, DNA polymerase P, 
carries out base excision repair necessary for DNA maintenance (Bhattacharyya and Banerjee, 
1997). A variant polymerase from deletion in the 87-bp region, in the heterozygous state, results in 
cells incapable of base excision repair and highly sensitive to the known group 2A animal 
carcinogen, N-methyl-N'-nitro-N-nitrosoguanidine (Bhattacharyya and Banerjee, 1997; Fujii and 
Nakadate, 1977). 
The index case in this report serves to suggest more frcqucnt gcnctic testing in the clinical scenario 
of early bronchopulmonary dysplasia in premature newborns will provide necessary data by 
- which to assess the prevalence of this potential complication of neonatal care. The archival cases 
reported here are a window onto new aspects of developn~ent of the human fetal brain. There are 
now four well documented examples of severe bronchopulmonary dysplasia related to heterozygous 
mutations in the ABCA3 transporter protein gene (Somaschini, et al., 2007 and this casc). The 
existence of an increasing number of instances where the heterozygous state carries significant risk 
burdens (as cited above) is a compelling argument for further study and clarification of the risk and 
the processes by which these disorders are manifested. 
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LEGEND FOR TABLE 
Table 1: Comparison of findings, indcx and archival cases. 
LEGENDS FOR FIGURES 
All photographs arc of tissues staincd by hematoxylin and eosin; original magnifications, 100X. 
Figure 1: Representative pulmonary lobule with extensive advanced fibrosis, mononuclear cell 
proliferation, and disordered vascular pattern. There are no competent peripheral 
air spaces and rare terminal bronchioles (not shown). This pattern was found 
throughout all five pulmonary lobes. 
Figure 2: Paraventricular germinal matrix, midzone, with irregular rcmnant clusters of primitive 
glioneuroblasts mingled with neural cell maturation in situ. Similar masses of immature 
migratory cells wcrc in stasis adjacent to and occasionally surrounding blood vessels 
in the influence of the middle cerebral arteries. 
Figure 3: Representative zone of parietal motor cortex. Layers of the cortical mantle are poorly 
arrayed; the locus of layer 5, across the middle of the view, lacks defined 
pyramidal and protopyramidal neurons. These are usually conspicuous by 30-3 1 weeks 
gestational age. 
Figure 4: Thyroid gland marked by dense interlacing fibrous septa which surround poorly 
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